Please assess the completion status of the following clinical trial:

Trial Title: Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* All patients 18 years of age or older.~* Patients must sign an informed consent.~* Patients should be in such a health condition in the opinion of the attending physician that with the administration of mifepristone benefits may outweigh risks.~Exclusion Criteria:~* Pregnant women or nursing mothers are not eligible for this trial. Patients of child bearing potential must use adequate contraception.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mifepristone (Type: EXPERIMENTAL): 200 mg RU-486 (Mifepristone) daily

Based on this trial design, predict the completion outcome and termination type (if applicable).